Clik here to view.
Korean CDISC Coordinating Committee Launched at 2019 Korea Summit
AUSTIN, Texas CDISC is pleased to announce the launch of the Korea CDISC Coordinating Committee (K3C) at the 2019 CDISC Korea Summit held 7 November in Daegu, South Korea. Dr. Maria Im Hee Shin of...
View ArticleClik here to view.
DS-8201 ([Fam-] Trastuzumab Deruxtecan) Achieved A Tumor Response Rate of...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today presented positive detailed data from the global pivotal phase 2...
View ArticleClik here to view.
PCI Pharma Services宣布巨额投资，扩建位于英国Tredegar厂区的开发和制造能力
费城 (美国商业资讯)–领先的制药和生物制药全球外包解决方案提供商PCI Pharma Services (PCI)今天宣布，已开始扩建其位于英国威尔士的Tredegar设施，以提升其高效价药物制造和开发能力，包括临床和商业两方面的供货。...
View ArticleClik here to view.
PCIファーマ・サービシズが英国トレデガー施設の開発・製造能力を拡大するための大規模投資を発表
フィラデルフィア (ビジネスワイヤ) — 世界規模で製薬／バイオ製薬アウトソーシングサービスを提供する一流企業のPCIファーマ・サービシズ（PCI）は本日、臨床供給および商業供給の両面において高薬理活性医薬品の製造・開発能力を強化すべく、英国ウェールズにある当社のトレデガー施設の拡張を開始したと発表しました。...
View ArticleClik here to view.
XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic...
NEW YORK & TOKYO Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the U.S. Food and Drug Administration...
View ArticleClik here to view.
山东方坦思宣布与杨森制药达成许可协议将开发抗IL-17A单克隆抗体并使其商业化
2019年12月17日[美国东部时间 (美国商业资讯)– 山东方坦思生制药有限公司（“方坦思”）今日宣布与强生公司旗下的一家杨森制药公司（“杨森”）签订独家许可、开发和商业化协议，在中华人民共和国（“中国”）包括香港特别行政区（“香港”）、澳门特别行政区（“澳门”）、台湾区域（“台湾”） 和韩国开发含有抗IL-17A单克隆抗体的医药产品并使其商业化。...
View ArticleClik here to view.
Shandong Fontacea Announces License Agreement with Janssen to Develop and...
JINAN, Shandong, People’s Republic of China Shandong Fontacea Pharmaceutical Co. Ltd. (“Fontacea”) announced today that it has entered into an exclusive license, development and commercialization...
View ArticleClik here to view.
Company Profile for Shandong Fontacea Pharmaceutical Co. Ltd.
About Shandong Fontacea Pharmaceutical Co. Ltd. Fontacea is a biopharmaceutical company dedicated to research, development and commercialization of innovative medicines for the global market,...
View ArticleClik here to view.
Pacific Prime China Wins Two Cigna & CMB Awards
SHANGHAI Pacific Prime, a leading insurance intermediary, has received two awards from Cigna & CMB, including the “Year 2019 Best Contributor Award” and “10 Year Anniversary Long-Term...
View ArticleClik here to view.
FDA Grants Accelerated Approval to Astellas’ and Seattle Genetics’ PADCEV™...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the U.S. Food and Drug...
View ArticleClik here to view.
Turnstone Biologics Announces Global Collaboration and License Agreement with...
NEW YORK Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies, today announced a strategic collaboration with Takeda Pharmaceutical Company...
View ArticleClik here to view.
Merck’s KEYTRUDA® (pembrolizumab) Approved in Japan for Three New First-Line...
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, received new approvals from the Japan Pharmaceuticals...
View ArticleClik here to view.
DAIKO Will Exhibit in CES 2020
TOKYO & OSAKA, Japan DAIKO hosts [JAPAN TECH] in cooperation with CREATIVE VISION and Filament. [JAPAN TECH] has chosen nine start-ups and supports their exhibition for CES 2020. This press...
View ArticleClik here to view.
心不全発症率の増加を抑制するための大規模なランダム化対照試験
ボストン （ビジネスワイヤ） — 心臓発作患者さんの治療方法を変えることで心不全発症率を低減させる有望な新療法を追究するピボタル多施設臨床試験が、現在進行中です。ST上昇型心筋梗塞（STEMI) ドア・ツー・アンローディング（DTU）ピボタルランダム化対照試験（STEMI...
View ArticleClik here to view.
Masimo和德尔格扩大授权协议以添加Masimo脑监护和二氧化碳分析技术
加州尔湾和德国吕贝克 (美国商业资讯)–Masimo (NASDAQ: MASI)和德尔格(Dräger, OTCMKTS: DRWKF)今天宣布，两家公司已扩大合作，德尔格将在该公司的多参数患者监护仪家族中集成添加Masimo测量技术，以帮助临床工作者评估脑功能、氧合和通气状态。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
マシモとドレーゲルがライセンス契約を拡大し、マシモの脳機能モニタリングとカプノグラフィーの技術を追加
米カリフォルニア州アーバイン & 独リューベック （ビジネスワイヤ） — マシモ（NASDAQ: MASI）とドレーゲル（OTCMKTS: DRWKF）は本日、提携関係の拡大を発表しました。ドレーゲルはマルチパラメーター患者モニターの自社ファミリーにマシモの新たな測定技術を搭載し、脳機能、酸素化、換気状態の評価で医師を支えます。...
View ArticleClik here to view.
寰宇保险代理中国公司荣获招商信诺两项大奖
上海 (美国商业资讯)–领先的保险中介寰宇保险代理(Pacific Prime)荣获招商信诺(Cigna & CMB)两项大奖，包括“2019年度最佳贡献奖”和“十周年长期合作奖”。招商信诺健康保险与福利十年年度感恩鸡尾酒会于2019年12月6日在静安香格里拉大酒店举行。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Shinkowa Pharmaceutical: Notice for the Conclusion of NMN Product’s Material...
TOKYO Shinkowa Pharmaceutical Co., Ltd. (Head Office: Chuo Ward, Tokyo CEO: Megumi Tanaka) sells Nutraceuticals and cosmetics containing more than 99% high purity β-nicotinamide mononucleotide...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Sodium Nitroprusside...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleClik here to view.
Urovant Sciences Majority Shareholder, Roivant Sciences, and Sumitomo...
IRVINE, Calif. & BASEL, Switzerland Urovant Sciences (Nasdaq: UROV) (“Urovant”) announced today that its majority shareholder, Roivant Sciences Ltd. (“Roivant”), and Sumitomo Dainippon Pharma...
View Article